Etihad Cargo has launched Pharmalife, a specialised pharma and healthcare service that replaces the carrier’s TempCheck service.
The new service is aimed at the anticipated global demand for swift and secure shipment services ahead of a COVID-19 vaccine.
Andre Blech, head of operations and service delivery, Etihad Cargo, commented:”The pandemic prompted a reassessment of our top-level services to ensure we can address the specific requirements for shipping high volumes of in-demand product in very short timescales,”
“To avoid last minute pressure once a vaccine is approved, we have established a dedicated COVID-19 vaccines workforce composed of a Steering Committee and a Working Group to manage all anticipated elements.”
Available at 54 stations on the Etihad network, PharmaLife will focus on key gateways including Abu Dhabi, Barcelona, Chicago, Paris, Dubai, Frankfurt, Hyderabad, London, Milan, Melbourne, Mumbai, Shanghai, Singapore, and Sydney.
“Pharma shipments are a key part of the global flow where every stakeholder has a responsibility to maintain product integrity,” said Blech. “Our intention is to continuously expand our Pharma trade lanes, which requires collaboration with industry partners. By working with equipment suppliers, general handling agents, and associations, we can share knowledge and build trust across the industry that will result in the highest quality industry standard for sustainable quality that our customers deserve.
PharmaLife will enhance the already available industry-leading services and features offered by Etihad Cargo. As part of the role out, Etihad Cargo is currently reviewing the refurbishment of a dedicated pharmaceutical handling facility to accommodate increased capacity at its hub in Abu Dhabi, as well as further thermal covers, and enhanced capabilities at origin stations based on pharma trade lanes and specific requests.